biOasis Technologies Inc. has developed and is now commercializing the ground-breaking Transcend Platform for the delivery of therapeutic compounds across the blood-brain barrier (BBB) and into the Central Nervous System (CNS) for the treatment of neurological diseases. The presentations below give an overview of the company and key developments of the Transcend Platform.

Presentation2016
Q2 – 2016
Presentation2015
Q1 – 2015